On March 4, 2021, Ruibo (Hangzhou) Pharmaceutical Technology Co., Ltd. closed the transaction. The company has recently completed the registration of the industrial and commercial change of capital increase and obtained a new business license renewed by the Hangzhou Market Supervision Administration.